U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5979328

Vehicular Impact Signaling Device

An apparatus for the deployment of a visible plume to alert other motorists that a proximate motor vehicle has been involved in a collision.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Pfizer Inc.


Number of patents: 22
Last date: May 08, 2012

NumberTitleIssue Date
8173394Systems and methods for protein production
The invention relates to systems and methods for producing proteins of interest. The invention employs genetically-engineered animal or plant cells that have modified protein folding or processing capacities. In one aspect, the invention features genetically-enginee...
05/08/2012
8168397Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
The present invention relates to methods for the control of virulence of infectious bacteria by modulating the extra-cellular concentration of bacterial cell signalling molecules. Derivatives of cell signalling molecules are conjugated to suitable carrier proteins a...
05/01/2012
8129504Oral delivery of modified transferrin fusion proteins
Pharmaceutical compositions containing modified fusion proteins of transferrin and therapeutic proteins or peptides with increased serum half-life or increased serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin mo...
03/06/2012
8129145Production of glycoproteins
An improved system for large scale production of glycoproteins in cell culture is provided. In accordance with the present invention, cells expressing a glycoprotein are grown in media that contain manganese at a concentration of between approximately 10 and 600 nM....
03/06/2012
8080243Isolated antibody which specifically binds to PCSK9
The present invention provides antagonizing antibodies, antigen-binding portions thereof, and aptamers that bind to proprotein convertase subtilisin kexin type 9 (PCSK9). Also provided are antibodies directed to peptides, in which the antibodies bind to PCSK9. The i...
12/20/2011
8034346Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
The present invention features methods for treating or preventing pain comprising administering an amount of a nerve growth factor antagonist (such as an anti-NGF antibody) and an amount of an NSAID such that together they provide effective pain relief. The inventio...
10/11/2011
7183294Indole derivatives useful for the treatment of diseases
The invention relates to indole derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The indole derivatives according to the present invention are useful in numerous...
02/27/2007
7138527Indole derivatives useful for the treatment of diseases
The invention relates to indole derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The indole derivatives according to the present invention are useful in numerous...
11/21/2006
6977261Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein R1, Q, Y, R2, R3, R4, R5, and n are as defi...
12/20/2005
69748223-isoquinolinone derivatives as matrix metalloproteinase inhibitors
This invention provides compounds defined by Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, Q, R2, R3, R4, and n are as defined in the specif...
12/13/2005
6949651Fused bicyclic metalloproteinase inhibitors
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula wherein A, B, X, Y, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of t...
09/27/2005
6924276Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
The invention provides dicarboxylic acid-substituted heteroaryl derivatives of the formula G1-(C(R1)R2)n-Q1-B-Q2-(C(R3)R4)m-G2  I or...
08/02/2005
6906092Method of inhibiting matrix metalloproteinases
The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I More particularly, the present invention relates to a m...
06/14/2005
6897223Pyridine fused bicyclic metalloproteinase inhibitors
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula wherein A, B, X, Y, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of t...
05/24/2005
6894057Oxo-azabicyclic compounds
A compound selected from those of formula (I): wherein: X1, X2, and X3, represent N or —CR3 in which R3 is as described in the...
05/17/2005
6881743Pyridine matrix metalloproteinase inhibitors
Selective MMP-13 inhibitors are pyridine derivatives of the formula or a pharmaceutically acceptable salt thereof, wherein: R1 and R2 independen...
04/19/2005
6869958Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein R1, Q, Y1, Y2, Y3, and R...
03/22/2005
6861555Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
Alcohol and water solvates of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt are crystalline and have the formula (I), wherein R1 is H or lower alkyl, and x is a number from 0 to 10, and are useful for treating dyslipidemia.
03/01/2005
6849648Phenylene alkyne matrix metalloproteinase inhibitors
A compound of Formula I or a pharmaceutically acceptable salt thereof, or a tautomer thereof, wherein G1, G2, and B are as defined in the application, are selective inhibi...
02/01/2005
6828326Pyrimidinone fused bicyclic metalloproteinase inhibitors
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula wherein A, B, X, Y, and R1 are as defined in the specification, and to pharmaceutical comp...
12/07/2004
6794497Aminofuranose compounds
The present invention provides compounds and methods of synthesizing furanose and aminofuranose compounds of Formula I which are useful fro treating rheumatoid arthritis, immunomodulatory diseases and disorders, inflamma...
09/21/2004
6747147Oxo-azabicyclic compounds
A compound selected from those of formula (I): wherein: X1, X2, and X3, represent N or —CR3 in which R3 is as described in the description, G1
06/08/2004
 
Sign InRegister
Username  
Password   
forgot password?